Related Experiment Video
Updated: Aug 15, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Racial Disparities in Technology Use in Children With Type 1 Diabetes: A Qualitative Content Analysis of Parents'
Carol J Howe1, Jennifer Morone2, Colin P Hawkes3
1Harris College of Nursing and Health Sciences, Texas Christian University, Fort Worth, Texas.
Racial disparities in diabetes technology use persist, influenced by parental perceptions. Non-Hispanic Black parents reported fears of stigma and provider barriers, unlike non-Hispanic White parents, highlighting areas for intervention.
Area of Science:
- Health disparities research
- Pediatric endocrinology
- Behavioral science
Background:
- Racial disparities in type 1 diabetes management are well-documented.
- Understanding parental perceptions is crucial for addressing these disparities.
- Diabetes technology use is a key area where inequities manifest.
Purpose of the Study:
- To explore and describe differences in perceptions between non-Hispanic Black (NHB) and non-Hispanic White (NHW) parents regarding factors influencing diabetes technology adoption.
- To identify specific patient and provider mechanisms contributing to racial disparities in technology use among youth with type 1 diabetes.
Main Methods:
- Qualitative study employing focus groups with parents of NHB and NHW children diagnosed with type 1 diabetes.
- Utilized Kilbourne's health disparities framework to guide data collection and initial analysis.
- Employed directed content analysis with inductive subcategory emergence for in-depth understanding.
Main Results:
- Five key subcategories emerged: child's choice, shame vs. pride, technology pros/cons, time frame, and blood glucose readiness indicators.
- NHB parents expressed concerns about technology malfunction, stigma associated with visible devices, and perceived gatekeeping by the diabetes team regarding technology access.
- NHW parents reported expectations of technology use from the diabetes team and did not identify similar provider-related barriers.
Conclusions:
- Findings illuminate patient and provider mechanisms contributing to racial disparities in diabetes technology use.
- Results underscore the need for interventions targeting patients, providers, and structural factors to promote equitable technology adoption.
- This research can inform strategies to improve type 1 diabetes management equity for all youth.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Bullying

